| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 102,268 | 95,740 | 100,171 | | Cost of Revenue | 74,299 | 73,383 | 75,895 | | | Gross Profit | 27,969 | 22,357 | 24,276 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 21,697 | 17,374 | 17,554 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,272 | 4,983 | 6,722 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 619 | 212 | 564 | | Earnings Before Interest And Taxes | 6,891 | 5,195 | 7,286 | | Interest Expense | 828 | 330 | 356 | | Income Before Tax | 6,063 | 4,865 | 6,930 | | Income Tax Expense | 1,514 | 1,574 | 1,826 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,549 | 3,291 | 5,104 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,549 | 3,291 | 5,104 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,549 | $3,291 | $5,104 |
|
0.24% Nasdaq 
0.20 (2.76%) 
Income Statement
